Holy Stone Healthcare Co., Ltd. (TPEX:4194)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.45
-0.08 (-1.06%)
May 8, 2026, 1:49 PM CST
Market Cap1.11B -6.0%
Revenue (ttm)n/a
Net Income-111.35M
EPS-0.76
Shares Out145.97M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume59,184
Average Volume218,757
Open7.32
Previous Close7.53
Day's Range7.18 - 7.60
52-Week Range5.32 - 12.65
Beta0.71
RSI48.94
Earnings DateMay 13, 2026

About Holy Stone Healthcare

Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis and SportVis, which are injectable medical devices for osteoarthritis and soft tissue injuries; TRUD, a medical device that contains a mixture of hyaluronic acid used for the treatment and prevention of ulcerative colitis in inflammatory bowel disease (IBD); and GAF, a gel for anal fissure healing. It also develops IBD98-M, an oral capsule that is in a Phase IIa trial for ulcera... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4194
Full Company Profile

Financial Performance

Financial Statements